Efficacy and safety of Shenyankangfu tablets for primary glomerulonephritis: study protocol for a randomized controlled trial

BACKGROUND: Chronic kidney disease is a common disease. Most chronic kidney diseases evolve from primary glomerulonephritis. Proteinuria is an independent risk factor for the progression of chronic kidney disease. The general consensus is that therapy administered to decrease proteinuria should incl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Trials
Main Authors: Kou, Jia, Wu, Jie, Yang, Hong-tao, He, Ya-ni, Fang, Jing-ai, Deng, Yue-yi, Xie, Yuan-sheng, Nie, Li-fang, Lin, Hong-li, Cai, Guang-yan, Chen, Xiang-mei
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4289030/
https://ncbi.nlm.nih.gov/pubmed/25480673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-15-479
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados